Ceftobiprole in Hospital Acquired Pneumonia

• Status: Completed
• Trial end date: 2007-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril (the water-soluble prodrug [form] of ceftobiprole) referred to as ceftobiprole versus a comparator in the treatment of patients with nosocomial pneumonia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Basilea Pharmaceutica
• Treatments: Ceftazidime; Ceftobiprole; Ceftobiprole medocaril; Cephalosporins; Linezolid

Criteria

Inclusion Criteria:

• Patients suffering from nosocomial pneumonia or ventilator-associated pneumonia

• Female patients must be postmenopausal for at least 1 year, surgically sterile, or practicing an effective method of birth control, before entry and throughout the study, and have a negative serum or urine pregnancy test at the screening

Exclusion Criteria:

• Known or suspected hypersensitivity to any related antibiotic medications

• Any known or suspected condition or concurrent treatment that would be contraindicated by the prescribing information

• Treatment with any investigational drug within 30 days before enrollment

• Prior enrollment to this study